<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231004059615N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-07-18</date_registration>
      <primary_sponsor>INTERNATIONAL SCIENCE AND TECHNOLOGY UNIVERSITY</primary_sponsor>
      <public_title>Effect of caffeine and beetroot juice supplementation on specific judo performance</public_title>
      <acronym></acronym>
      <scientific_title>The effect of caffeine and beetroot juice supplementation on specific judo performance during simulated competition-day conditions in judo athletes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84708</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Crossover, Purpose: Other, Randomization description: The names of the subjects will be entered in one column of Excel; in another column, each subject will be randomly assigned a number using the RAND function (=RAND()); then, the numbers will be sorted from smallest to largest; 25% of the subjects will receive Intervention 1 (caffeine supplement), 25% of the subjects will receive Intervention 2 (beetroot juice supplement), 25% of the subjects will receive Intervention 3 (caffeine + beetroot juice), and the remaining 25% will receive placebo. In the second to fourth sessions of the experiment, the subjects will be switched (for example, subjects who received Intervention 1 in the first session will be randomly assigned to Intervention 2, 3, or placebo in the second session), Blinding description: The order in which the beetroot juice supplement or placebo was administered will be determined by one outside the study and will not be disclosed to participants or researchers until after the data analysis. Participants will also receive the supplements and placebo in a capsule (caffeine) and a bottle (beetroot juice) that are opaque and look similar. In addition, the color and taste of the placebo will be simulated by adding food coloring and flavoring to the supplement.</study_design>
      <phase>3</phase>
      <hc_freetext>Improve exercise performance.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: Beetroot juice supplement (BEET It Sport®; James White Drinks Ltd., Ipswich, UK); 2 days before the test: 2 servings, 70 ml each, containing approximately 6.4 mmol nitrate;1 day before the test: 2 servings, 70 ml each, containing approximately 6.4 mmol nitrate;Test day: 2 servings, 2 hours before the test and after the second randori, 70 ml, containing approximately 6.4 mmol nitrate. Intervention 2: Intervention group 2: Caffeine supplement (Caffeine®, Olimp Laboratories, Poland); Test day: 3 servings, 1 hour before the test and after the second and fourth attempts, 2 mg/kg body weight each. Intervention 3: Intervention group 3: Beetroot juice supplement (BEET It Sport®; James White Drinks Ltd., Ipswich, UK); 2 days before the test: 2 servings, each 70 ml, containing approximately 6.4 mmol nitrate; 1 day before the test: 2 servings, each 70 ml, containing approximately 6.4 mmol nitrate; Test day: 2 servings, 2 hours before the test and after the second attempt, 70 ml, containing approximately 6.4 mmol nitrate. Caffeine supplement (Caffeine®, Olimp Laboratories, Poland); Test day: 3 servings, 1 hour before the test and after the second and fourth attempts, 2 mg/kg body weight each. Intervention 4: Control group: Similar to the intervention condition, they will receive placebo (colored water instead of beetroot juice and a capsule containing cellulose instead of caffeine).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data collected during the study will be shareable after de-identifying the subjects.

When:
The data will be published after the extracted articles are accepted.

To whom:
All people

Conditions:
All data collected during the study will be shareable after de-identifying the subjects. The requester will only be permitted to use the data for meta-analysis reviews.

Where to obtain:
Corresponding author: Davar Khodadadi, Faculty of Physical Education and Sports Sciences, Islamic Azad University Central Tehran Branch, Tehran, Iran Email: davar.khodadadi@yahoo.com

How to obtain:
Sending an email request to the corresponding author: Davar Khodadadi Email: davar.khodadadi@yahoo.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Davar Khodadadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Physical Education and Sports Sciences, Velayat University Complex, Shahid Sohani St., Sohank</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1955847781</zip>
        <telephone>+98 21 2263 3583</telephone>
        <email>davar.khodadadi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Davar Khodadadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Physical Education and Sports Sciences, Velayat University Complex, Shahid Sohani St., Sohank</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1955847781</zip>
        <telephone>+98 21 2263 3583</telephone>
        <email>davar.khodadadi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Turkey</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All male judokas between the ages of 18 and 30.
Have a training history of more than 5 years.
Have at least a brown belt in judo.
Do not smoke.
Do not drink alcohol.
Have a daily caffeine intake of less than 100 mg.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Have any illness or injury in the past 3 months
Take any medication or nutritional supplement in the past 3 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: Beetroot juice supplement (BEET It Sport®; James White Drinks Ltd., Ipswich, UK); 2 days before the test: 2 servings, 70 ml each, containing approximately 6.4 mmol nitrate;1 day before the test: 2 servings, 70 ml each, containing approximately 6.4 mmol nitrate;Test day: 2 servings, 2 hours before the test and after the second randori, 70 ml, containing approximately 6.4 mmol nitrate.</i_keyword>
      <i_keyword>Intervention group 2: Caffeine supplement (Caffeine®, Olimp Laboratories, Poland); Test day: 3 servings, 1 hour before the test and after the second and fourth attempts, 2 mg/kg body weight each.</i_keyword>
      <i_keyword>Intervention group 3: Beetroot juice supplement (BEET It Sport®; James White Drinks Ltd., Ipswich, UK); 2 days before the test: 2 servings, each 70 ml, containing approximately 6.4 mmol nitrate; 1 day before the test: 2 servings, each 70 ml, containing approximately 6.4 mmol nitrate; Test day: 2 servings, 2 hours before the test and after the second attempt, 70 ml, containing approximately 6.4 mmol nitrate. Caffeine supplement (Caffeine®, Olimp Laboratories, Poland); Test day: 3 servings, 1 hour before the test and after the second and fourth attempts, 2 mg/kg body weight each</i_keyword>
      <i_keyword>Control group: Similar to the intervention condition, they will receive placebo (colored water instead of beetroot juice and a capsule containing cellulose instead of caffeine).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>SJFT index. Timepoint: In the 6 stages after judo randori. Method of measurement: Using the following formula: SJFT index = HR0 + HR1 / total number of throws.</prim_outcome>
      <prim_outcome>Cognitive function. Timepoint: At baseline and after SJFT. Method of measurement: Using the Psychomotor Vigilance Test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Number of throws. Timepoint: In the 6 stages after SJFT. Method of measurement: Counting the number.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: In the 6 stages immediately at the end of SJFT and 1 minute after SJFT. Method of measurement: Using a Polar heart rate monitor.</sec_outcome>
      <sec_outcome>Rate of perceived exertion. Timepoint: In the 6 stages after SJFT. Method of measurement: Using the Borg scale.</sec_outcome>
      <sec_outcome>Jump height. Timepoint: In the 6 stages (pre-exercise and after SJFT). Method of measurement: CMJ Test.</sec_outcome>
      <sec_outcome>Muscular strength. Timepoint: In the 6 stages (pre-exercise and after SJFT). Method of measurement: Isometric strength testing device for hand muscles.</sec_outcome>
      <sec_outcome>Blood lactate. Timepoint: At baseline, pre-exercise, mid-exercise, pre-final SJFT and post-exercise. Method of measurement: Via Enzyme-Linked Immunosorbent Assay.</sec_outcome>
      <sec_outcome>Muscle oxygenation. Timepoint: During the final SJFT. Method of measurement: Near-infrared spectroscopy.</sec_outcome>
      <sec_outcome>Blood glucose. Timepoint: At baseline, pre-exercise, mid-exercise, pre-final SJFT and post-exercise. Method of measurement: Via hexokinase method.</sec_outcome>
      <sec_outcome>Plasma nitrate and nitrite. Timepoint: At baseline, pre-exercise, mid-exercise, pre-final SJFT and post-exercise. Method of measurement: Via chemiluminescence assay.</sec_outcome>
      <sec_outcome>Blood caffeine. Timepoint: At baseline, pre-exercise, mid-exercise, pre-final SJFT and post-exercise. Method of measurement: Via High-Performance Liquid Chromatography.</sec_outcome>
      <sec_outcome>Blood PH. Timepoint: At baseline and post-exercise. Method of measurement: Blood gas analyzer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>INTERNATIONAL SCIENCE AND TECHNOLOGY UNIVERSITY</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-03</approval_date>
        <contact_name>Ethics Committee of the International Science and Technology University</contact_name>
        <contact_address>Tunahan Mah. Dumlupinar 30 Agustos Cad. No:2, Metromal Business F Blok Office Ankara Ankara Turkey</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
